Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05860972 · ClinicalTrials.gov registry record · NA
Evaluation of Safety and Efficacy of Morpheus8 Applicator for the Treatment of Focal Hyperhidrosis of the Axillae Using Radio Frequency
A NA study of Hyperhidrosis Primary Focal Axilla, sponsored by InMode MD.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 4
- Study locations
NCT05860972 is a NA study of Hyperhidrosis Primary Focal Axilla that is actively recruiting participants, run by InMode MD. The registered enrollment target is 70 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT05860972, a NA study of Hyperhidrosis Primary Focal Axilla, is actively recruiting participants, sponsored by InMode MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 4
- Study locations
Study Summary
The InMode radio frequency Pro System with the Morpheus8 Applicator is a computerized system generating radio frequency energy, based on the underlying technology of Fractional RF. The Morpheus8 Applicator and 24 pin tip is used for the treatment of primary hyperhidrosis of the axillae
Conditions Studied
Interventions
- DEVICE Morpheus8 Applicator (with the 24 pin tip) in the treatment of primary axillary hyperhidrosis.
Study Locations (4)
New York
- Skinfluence - New York
Tennessee
- Southeastern Dermatology - Knoxville
Texas
- Dallas Plastic Surgery Institute - Dallas
Other
- RAMBAM Medical Center - Haifa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-03-09 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05860972
The ClinicalTrials.gov registry entry for NCT05860972 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InMode MD, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hyperhidrosis Primary Focal Axilla appearing as the primary indexed condition, and to 1 intervention - of which Morpheus8 Applicator (with the 24 pin tip) in the treatment of primary axillary hyperhidrosis. is the first listed.
NCT05860972 reports 4 study locations spanning 4 distinct geographic areas - top geographies include New York, Tennessee, Texas.
Frequently Asked Questions
What is clinical trial NCT05860972 about?
NCT05860972 is a clinical study titled "Evaluation of Safety and Efficacy of Morpheus8 Applicator for the Treatment of Focal Hyperhidrosis of the Axillae Using Radio Frequency". The InMode radio frequency Pro System with the Morpheus8 Applicator is a computerized system generating radio frequency energy, based on the underlying technology of Fractional RF. The Morpheus8 Applicator and 24 pin tip is used for the treatment of primary hyperhidrosis of the axillae
What is the current status of trial NCT05860972?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-03-09. Estimated completion is 2026-04.
What conditions does trial NCT05860972 study?
This clinical trial studies the following conditions: Hyperhidrosis Primary Focal Axilla.
What interventions are being tested in trial NCT05860972?
The interventions under investigation include: Morpheus8 Applicator (with the 24 pin tip) in the treatment of primary axillary hyperhidrosis. (DEVICE).
Who is sponsoring clinical trial NCT05860972?
This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05860972 being conducted?
This trial has 4 study locations across New York, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.